Access investigational medicines for Lewy body dementia on a clinical trial
Re:Cognition Health, a world-leading centre for late phase international clinical trials for Alzheimer’s and dementia research, is currently enrolling volunteers with a Lewy body dementia diagnosis to take part in a trial to help test potential new treatments.
Clinical trials are imperative, helping us understand more about dementia and also enable us to develop new strategies to diagnose diseases as well as helping to develop and test essential, potential treatments. Volunteers participating in clinical studies at Re:Cognition Health Centres receive world-class health care including comprehensive health screens, MRI scans and PET scans and regular monitoring by the highly-skilled team of cognitive experts, at no cost. Clinical trial participants also receive a contribution to travel costs to appointments, and refreshments are provided.
Taking part in a clinical trial for Lewy body dementia gives individuals access to investigational medicines for the disease, as well as the personal privilege of being part of much-needed research to find medications, and ultimately a cure for Lewy body dementia.
Volunteers aged 50 – 85 years old with a diagnosis of Lewy body dementia who have experienced hallucinations are eligible to take part in the trial.
For further information, visit: https://recognitionhealth.com/dementia-with-lewy-bodies-treatment/